Allogeneic hematopoietic cell transplantation with double alkylating agents containing reduced intensity conditioning for patients ≥60 years with advanced AML/MDS
Bertz, H, Lübbert, M, Ohneberg, K, Zeiser, R, Wäsch, R, Marks, R, Finke, JLanguage:
english
Journal:
Leukemia
DOI:
10.1038/leu.2016.248
Date:
August, 2016
File:
PDF, 1011 KB
english, 2016